homeostasis/metabolism
• lipid infusion does not alter insulin sensitivity, muscular and brown fat adipose tissue glucose uptake, or whole-body and muscular metabolic flux, including glycolysis and glycogen synthesis, unlike in similarly treated wild-type mice
|
• lipid infused mice do not exhibit a decrease in insulin sensitivity compared with similarly treated wild-type mice
|
immune system
N |
• mice exhibit normal regulatory T cells-mediated inhibition of T cell activation, IL2-induced expansion of regulatory T cells, and regulatory T cells TGF-beta production
|
• following CD3 and CD28 stimulation, T cell apoptosis is accelerated compared to in similarly treated wild-type cells
|
• when stimulated by anti-CD3 antibodies or antigens (in vitro and in vivo)
|
• mildly impaired
|
• the ratio of CD4 to CD8 T cells is lower than in wild-type mice
|
adipose tissue
• lipid infusion does not alter brown adipose tissue glucose uptake unlike in wild-type mice
• however, white adipose tissue glucose uptake is similarly decreased following lipid infusion as in wild-type mice
|
muscle
• lipid infusion does not alter muscle glucose uptake unlike in wild-type mice
|
hematopoietic system
• following CD3 and CD28 stimulation, T cell apoptosis is accelerated compared to in similarly treated wild-type cells
|
• when stimulated by anti-CD3 antibodies or antigens (in vitro and in vivo)
|
• mildly impaired
|
• the ratio of CD4 to CD8 T cells is lower than in wild-type mice
|
cellular
• lipid infusion does not alter brown adipose tissue glucose uptake unlike in wild-type mice
• however, white adipose tissue glucose uptake is similarly decreased following lipid infusion as in wild-type mice
|
• following CD3 and CD28 stimulation, T cell apoptosis is accelerated compared to in similarly treated wild-type cells
|
• when stimulated by anti-CD3 antibodies or antigens (in vitro and in vivo)
|
• lipid infusion does not alter muscle glucose uptake unlike in wild-type mice
|
endocrine/exocrine glands